WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+6.72%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$3.05B
AUM Growth
+$527M
(+21%)
Cap. Flow
+$440M
Cap. Flow
% of AUM
14.43%
Top 10 Holdings %
Top 10 Hldgs %
28.17%
Holding
230
New
83
Increased
48
Reduced
47
Closed
52
Top Buys
| 1 |
Microchip Technology
MCHP
|
$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$66.5M |
| 3 |
Amazon
AMZN
|
$65.6M |
| 4 |
Mastercard
MA
|
$63.4M |
| 5 |
Johnson & Johnson
JNJ
|
$61.5M |
Top Sells
| 1 |
Intel
INTC
|
$64.7M |
| 2 |
PayPal
PYPL
|
$52M |
| 3 |
eBay
EBAY
|
$48.4M |
| 4 |
NXP Semiconductors
NXPI
|
$42.9M |
| 5 |
Qorvo
QRVO
|
$42M |
Sector Composition
| 1 | Healthcare | 44.94% |
| 2 | Technology | 31.58% |
| 3 | Communication Services | 6.58% |
| 4 | Consumer Discretionary | 4.22% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tango Therapeutics
TNGX
$772M
| $5.18M | 0.17% |
+500,000
| New | +$5.18M |
|
127
Ericsson
ERIC
$26.7B
| $5.08M | 0.17% |
+466,103
| New | +$5.08M |
|
128
Nurix Therapeutics
NRIX
$758M
| $5.03M | 0.16% |
+144,087
| New | +$5.03M |
|
129
Immunovant
IMVT
$2.99B
| $4.97M | 0.16% |
141,170
-89,738
| -39% | -$3.16M |
|
130
NetApp
NTAP
$23.7B
| $4.96M | 0.16% |
+113,217
| New | +$4.96M |
|
131
Avidity Biosciences
RNA
$6.48B
| $4.87M | 0.16% |
172,978
+47,978
| +38% | +$1.35M |
|
132
DaVita
DVA
$9.86B
| $4.77M | 0.16% |
+55,720
| New | +$4.77M |
|
133
CommScope
COMM
$3.55B
| $4.63M | 0.15% |
514,299
+122,954
| +31% | +$1.11M |
|
|
FSDC
134
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $4.63M | 0.15% |
+413,332
| New | +$4.63M |
|
135
Zentalis Pharmaceuticals
ZNTL
$126M
| $4.51M | 0.15% |
137,884
+94,158
| +215% | +$3.08M |
|
136
Icon
ICLR
$13.6B
| $4.51M | 0.15% |
+23,580
| New | +$4.51M |
|
|
137
Intel
INTC
$107B
| $4.44M | 0.15% |
85,814
-1,249,446
| -94% | -$64.7M |
|
138
Nu Skin
NUS
$569M
| $4.44M | 0.15% |
+88,581
| New | +$4.44M |
|
139
Orchestra BioMed
OBIO
$148M
| $4.4M | 0.14% |
+400,000
| New | +$4.4M |
|
140
Analog Devices
ADI
$122B
| $4.21M | 0.14% |
36,051
-62,578
| -63% | -$7.31M |
|
141
Cadence Design Systems
CDNS
$95.6B
| $4M | 0.13% |
37,474
-111,662
| -75% | -$11.9M |
|
|
PRVL
142
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $3.92M | 0.13% |
385,480
+56,345
| +17% | +$574K |
|
143
Envista
NVST
$3.54B
| $3.89M | 0.13% |
157,621
+107,506
| +215% | +$2.65M |
|
144
Arrowhead Research
ARWR
$4.02B
| $3.76M | 0.12% |
+87,365
| New | +$3.76M |
|
|
SUMO
145
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.6M | 0.12% |
+165,000
| New | +$3.6M |
|
|
CMPS
146
Compass Pathways
CMPS
$493M
| $3.59M | 0.12% |
+102,944
| New | +$3.59M |
|
147
CVS Health
CVS
$93.6B
| $3.59M | 0.12% |
+61,476
| New | +$3.59M |
|
148
GoodRx Holdings
GDRX
$1.39B
| $3.48M | 0.11% |
+62,500
| New | +$3.48M |
|
149
Pliant Therapeutics
PLRX
$114M
| $3.44M | 0.11% |
+152,000
| New | +$3.44M |
|
|
FRLN
150
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $3.22M | 0.11% |
+13,761
| New | +$3.22M |
|